A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Conditions
- Relapsed/Refractory Hematological Malignancies
- Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL
- Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation)
- Relapsed/Refractory Mantle Cell Lymphoma (MCL)
- Relapsed/Refractory Waldenström Macroglobulinemia (WM)
- Relapsed/Refractory Marginal Zone Lymphoma (MZL)
- Relapsed/Refractory Follicular Lymphoma (FL)
Interventions
Sponsor
Ascentage Pharma Group Inc.